Herbs (Global Traditional) · African
Hypoxis hemerocallidea
Moderate Evidencebotanical1 PubMed Study
Hermetica Superfood Encyclopedia
Hypoxis hemerocallidea is an African medicinal plant containing hypoxoside and rooperol as primary bioactive compounds. These compounds demonstrate blood sugar regulation and antioxidant activity through enhanced hepatic antioxidant enzyme systems.
Hypoxis hemerocallidea, commonly known as African potato, is a perennial herbaceous plant native to Southern Africa, particularly South Africa, belonging to the Hypoxidaceae family. The medicinal parts are primarily the corms (underground stems), from which aqueous, methanolic, or other extracts are obtained through methods like maceration or infusion in water or solvents.
Clinical evidence is limited to preclinical animal studies and small human pharmacokinetic trials, with no human RCTs identified. Key studies include a rat diabetes model (n=60, PMID: 27403200) showing 73.3% blood glucose reduction, and a mouse colitis study (PMID: 20404038) demonstrating anti-inflammatory effects. Human data consists only of pharmacokinetic interaction studies (n=16) showing no interaction with HIV medications (PMID: 19374071).
Animal studies used aqueous extract at 200-800 mg/kg body weight daily. Human pharmacokinetic studies used 15 mg/kg hypoxoside content once daily for 7 days. No standardized therapeutic dosage has been established for clinical use. Consult a healthcare provider before starting any new supplement.
Hypoxis hemerocallidea (African Potato) corm is not typically consumed as a food for macronutrient value but rather as a medicinal preparation. Key bioactive compounds include: • Hypoxoside: The primary norlignan diglucoside, found at approximately 3.5–5.0% dry weight in the corm; upon hydrolysis by β-glucosidase (including gut flora enzymes), it converts to the biologically active aglycone rooperol. • Rooperol: A potent dicatechol with strong antioxidant and cytotoxic properties; bioavailability is dependent on enzymatic deconjugation in the gastrointestinal tract, with oral bioavailability estimated to be moderate but variable. • Sterols and sterolins: Contains β-sitosterol (~0.05–0.1% dry weight) and its glucoside β-sitosterol glucoside (BSS:BSSG ratio approximately 100:1 in standardized extracts), which are credited with immunomodulatory activity. • Phenolic acids: Includes gallic acid, protocatechuic acid, and caffeic acid derivatives contributing to total phenolic content of approximately 15–25 mg GAE/g dry extract. • Flavonoids: Quercetin and kaempferol glycosides detected at lower concentrations (~2–5 mg/g dry extract). • Stanols and fatty acids: Minor amounts of stigmasterol and campesterol; trace long-chain fatty acids. • Minerals: Corm contains potassium (~800–1200 mg/100g dry weight), calcium (~150–300 mg/100g), magnesium (~100–200 mg/100g), iron (~5–15 mg/100g), and zinc (~2–5 mg/100g), though these values vary significantly with soil conditions and geographic origin. • Fiber: The corm is rich in dietary fiber (~30–45% dry weight), predominantly insoluble fiber including cellulose and hemicellulose. • Protein: Low protein content (~3–6% dry weight). • Carbohydrates: Starch-rich corm with total carbohydrates approximately 40–55% dry weight. • Vitamins: Limited data; trace amounts of vitamin C and B-complex vitamins have been reported. • Bioavailability notes: Hypoxoside is water-soluble and well-absorbed orally but requires enzymatic conversion to rooperol for biological activity; β-sitosterol has inherently low oral bioavailability (~5–10%) which is improved in glucoside form; traditional aqueous decoction preparation extracts primarily hypoxoside and polar phenolics while sterol extraction is enhanced with lipid-based or ethanolic preparations.
Hypoxis hemerocallidea's primary bioactives hypoxoside and rooperol enhance hepatic antioxidant enzyme systems including catalase and glutathione peroxidase. The compounds appear to modulate glucose metabolism through improved insulin sensitivity pathways. These mechanisms contribute to both glycemic control and oxidative stress reduction in metabolic tissues.
Current evidence for Hypoxis hemerocallidea relies primarily on animal studies rather than human trials. In diabetic rat models, 200 mg/kg aqueous extract reduced blood glucose levels by 73.3% after 6 weeks of treatment. The same studies showed significant elevation of hepatic antioxidant markers including ORAC, FRAP, and catalase activity. Human clinical data remains limited, making evidence strength preliminary at this stage.
Safety data for Hypoxis hemerocallidea in humans is limited due to lack of comprehensive clinical trials. No significant adverse effects were reported in available animal studies at therapeutic dosages. Potential interactions with diabetes medications should be monitored due to glucose-lowering effects. Pregnant and breastfeeding women should avoid use due to insufficient safety data.
